Medication-info.com Search Menu

Zarxio (Filgrastim): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
300 mcg/0.5 mL, 480 mcg/0.8 mL
Other brand names:
Active ingredient:

Patient information: uses, side effects, how to take - Zarxio

What is ZARXIO?

ZARXIO is a man-made form of granulocyte colony-stimulating factor (G‑CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.

Acute Radiation Syndrome: The effectiveness of filgrastim for this use was only studied in animals, because it could not be studied in people.

Do not take ZARXIO if you have had a serious allergic reaction to human G-CSFs such as filgrastim products or pegfilgrastim products.

Before you take ZARXIO, tell your healthcare provider about all of your medical conditions, including if you:

  • have a sickle cell disorder.
  • have kidney problems.
  • are receiving radiation therapy.
  • are pregnant or plan to become pregnant. It is not known if ZARXIO will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if ZARXIO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive ZARXIO?

  • ZARXIO injections can be given by a healthcare provider by intravenous (IV) infusion or under your skin (subcutaneous injection). Your healthcare provider may decide subcutaneous injections can be given at home by you or your caregiver. If ZARXIO is given at home, see the detailed “Instructions for Use” that comes with your ZARXIO for information on how to prepare and inject a dose of ZARXIO.
  • You and your caregiver should be shown how to prepare and inject ZARXIO before you use it, by your healthcare provider.
  • Your healthcare provider will tell you how much ZARXIO to inject and when to inject it. Do not change your dose or stop ZARXIO unless your healthcare provider tells you to.
  • You should not inject a dose of ZARXIO less than 0.3 mL (180 mcg) from a ZARXIO prefilled syringe. A dose less than 0.3 mL cannot be accurately measured using the ZARXIO prefilled syringe.
  • If you are receiving ZARXIO because you are also receiving chemotherapy, your dose of ZARXIO should be injected at least 24 hours before or 24 hours after your dose of chemotherapy. Your healthcare provider will do blood tests to monitor your white blood cell count, and if necessary, adjust your ZARXIO dose.
  • If you are receiving ZARXIO because you have been suddenly (acutely) exposed to an amount of radiation that can affect your bone marrow (Acute Radiation Syndrome), you will need to have blood tests about every 3 days during treatment with ZARXIO to check your white blood cell count.
  • If you miss a dose of ZARXIO, talk to your healthcare provider about when you should give your next dose.

What are the possible side effects of ZARXIO?

ZARXIO may cause serious side effects, including:

  • Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach (abdomen) area or your left shoulder.
  • A serious lung problem called acute respiratory distress syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious allergic reactions. ZARXIO can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using ZARXIO and call your healthcare provider or get emergency medical help right away.
  • Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive ZARXIO. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.
  • Kidney injury (glomerulonephritis). ZARXIO can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:

    • swelling of your face or ankles
    • blood in your urine or dark colored urine
    • you urinate less than usual
  • Capillary leak syndrome. ZARXIO can cause fluid to leak from blood vessels into your body’s tissues. This condition is called “Capillary Leak Syndrome” (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:

    • swelling or puffiness and are urinating less than usual
    • trouble breathing
    • swelling of your stomach area (abdomen) and feeling of fullness
    • dizziness or feeling faint
    • a general feeling of tiredness
  • Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).

    • ZARXIO may increase the risk of developing a precancerous condition called MDS or a type of blood cancer called AML in people who were born with low white blood cell counts (congenital neutropenia).
    • If you have breast cancer or lung cancer, when ZARXIO is used with chemotherapy and radiation therapy, or with radiation therapy only, you may have an increased risk of developing MDS or AML.
    • Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding.
    • Call your healthcare provider if you develop any of these symptoms during treatment with ZARXIO.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with ZARXIO. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with ZARXIO. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with ZARXIO.
  • Inflammation of your blood vessels (cutaneous vasculitis). Tell your healthcare provider right away if you develop purple spots or redness of your skin.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received filgrastim products. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effects experienced in patients receiving ZARXIO include:

  • Patients with cancer receiving chemotherapy: fever, pain, rash, cough, and shortness of breath
  • Patients with acute myeloid leukemia receiving chemotherapy: pain, nose bleed, and rash
  • Patients with cancer receiving chemotherapy followed by bone marrow transplant: rash
  • Patients who are having their own blood cells collected: bone pain, fever, and headache
  • Patients with severe chronic neutropenia: pain, decreased red blood cells, nose bleed, diarrhea, reduced sensation, and hair loss

These are not all the possible side effects of ZARXIO.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ZARXIO?

  • Store ZARXIO in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze.
  • Store ZARXIO in the original pack to protect it from light or physical damage. Do not leave ZARXIO in direct sunlight.
  • Do not shake ZARXIO.
  • Take ZARXIO out of the refrigerator 30 minutes before use and allow it to reach room temperature between 68°F to 77°F (20°C to 25°C) before preparing an injection.
  • If not used right away, ZARXIO may be kept at room temperature for up to 8 days. Throw away any ZARXIO that has been left at room temperature for longer than 8 days.
  • After you inject your dose, throw away (dispose of) any unused ZARXIO left in the prefilled syringe or vial. Do not save unused ZARXIO in the prefilled syringe or vial for later use.
  • The prefilled syringe with safety guard is not made with natural rubber latex.
  • The vial stopper is not made with natural rubber latex.

Keep ZARXIO and all medicines out of the reach of children.

General information about the safe and effective use of ZARXIO:

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ZARXIO for a condition for which it was not prescribed. Do not give ZARXIO to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about ZARXIO that is written for healthcare professionals.

What are the ingredients in ZARXIO?

Active ingredient: filgrastim-sndz

Inactive ingredients: glutamic acid, polysorbate 80, sodium hydroxide, sorbitol, water for injection

Manufactured by: Sandoz Inc., Princeton, NJ 08540, US License No. 2003

For more information visit www.zarxio.com or call 1-800-525-8747.

This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: 04/2025

Instructions for Use

ZARXIO® (zar-zee-oh)

(filgrastim-sndz)

injection

Single-Dose Prefilled Syringe

Important Information You Need to Know Before Injecting ZARXIO:

  • Do not inject yourself or someone else until you have been shown how to inject ZARXIO. Your healthcare provider will show you how to prepare and inject ZARXIO properly using the ZARXIO prefilled syringe with UltraSafe Passive® Needle Guard. Talk to your healthcare provider if you have any questions.
  • Do not use the ZARXIO prefilled syringe if there is liquid in the plastic tray. Do not use the ZARXIO prefilled syringe if the needle cap is missing or not securely attached. In all these cases, return the entire pack to the pharmacy.
  • Do not inject a dose less than 0.3 mL (180 mcg) from a ZARXIO prefilled syringe. A dose less than 0.3 mL cannot be accurately measured using the ZARXIO prefilled syringe.
  • Do not use the ZARXIO prefilled syringe if either the seal on the outer pack or the seal of the blister are broken.
  • Keep the ZARXIO prefilled syringe in the sealed pack until you are ready to use it.
  • The prefilled syringe has a needle guard that will be activated to cover the needle after the injection is given. The needle guard will help prevent needle stick injuries to anyone who handles the prefilled syringe.
  • Avoid touching the syringe needle guard wings before use. Touching them may cause the syringe needle guard to be activated too early.
  • Do not remove the needle cap until just before you give the injection.
  • Throw away (dispose of) the used ZARXIO prefilled syringe right away after use. Do not re-use a ZARXIO prefilled syringe. See “Disposing of used ZARXIO prefilled syringes” at the end of this Instructions for Use.
  • Do not use if the syringe has been dropped onto a hard surface or dropped after removing the needle cap.
  • Note: The ZARXIO prefilled syringe with safety guard is not made with natural rubber latex.

Storing ZARXIO

  • Store ZARXIO in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze ZARXIO. If frozen, thaw in the refrigerator before use. Throw away (dispose of) if it has been frozen more than 1 time.
  • Store ZARXIO in the original pack to protect it from light.
  • Do not shake the ZARXIO prefilled syringe.
  • Take ZARXIO out of the refrigerator 30 minutes before use and allow it to reach room temperature between 68°F to 77°F (20°C to 25°C) before preparing an injection.
  • If not used right away, ZARXIO may be kept at room temperature for up to 8 days. Throw away (dispose of) any ZARXIO that has been left at room temperature for longer than 8 days.
  • After you inject your dose, throw away (dispose of) any unused ZARXIO left in the prefilled syringe. Do not save unused ZARXIO in the prefilled syringe for later use.

Keep ZARXIO and all medicines out of the reach of children.

About the ZARXIO prefilled syringe:

  • ZARXIO prefilled syringes come in two strengths. Depending on your prescription, you will receive ZARXIO prefilled syringes that contain 300 mcg/0.5 mL or 480 mcg/0.8 mL of medicine. Your healthcare provider will determine the microgram (mcg) dose in milliliters (mL) that you will need to give based on your body weight. When you receive your ZARXIO prefilled syringes, always check to see that the:

    • name ZARXIO appears on the pack and prefilled syringe label.
    • expiration date on the prefilled syringe label has not passed. You should not use a prefilled syringe after the date on the label.
    • strength of ZARXIO (number of mcg on the pack containing the prefilled syringe) is the same as what your healthcare provider prescribed.

ZARXIO prefilled syringe parts (see Figure A). ZARXIO 300 mcg /0.5 mL prefilled syringe is shown as an example.

Figure A ZARXIO prefilled syringe with needle guard

What you need for your injection:

Included in the pack:

  • A new ZARXIO prefilled syringe (see Figure A above)

Not included in the pack (see Figure B):

  • 1 Alcohol wipe
  • 1 Cotton ball or gauze
  • Sharps disposal container
  • 1 Adhesive bandage

Figure B Additional items needed (not included in the pack)

See “Disposing of used ZARXIO prefilled syringes” at the end of this Instructions for Use.

Preparing the ZARXIO prefilled syringe

Step 1. Find a clean, well-lit, flat work surface.

Step 2. Take the pack containing the ZARXIO prefilled syringe out of the refrigerator and leave it unopened on your work surface for about 30 minutes so that it reaches room temperature.

Step 3. Wash your hands well with soap and water.

Step 4. Remove the ZARXIO prefilled syringe blister from the outer pack. Hold the prefilled syringe in the middle as shown to remove it from the blister (see Figure C). Do not grab the plunger rod. Do not grab the needle cap.

Figure C Remove the prefilled syringe from the blister

Step 5. Check the expiration date. Do not use the ZARXIO prefilled syringe if the expiration date has passed.

Step 6. Look through the viewing window on the ZARXIO prefilled syringe. The liquid inside should be clear. The color may be colorless to slightly yellowish. You may see a small air bubble in the liquid. This is normal. Do not use the prefilled syringe if the liquid contains visible particles, or if the liquid is cloudy or discolored. Return the ZARXIO prefilled syringe and the package it came in to your pharmacy.

Step 7. Do not use a ZARXIO prefilled syringe if it is broken. Return the broken prefilled syringe and the package it came in to your pharmacy.

Step 8. Check to make sure that the plastic transparent needle guard is covering the barrel of the glass syringe. If the transparent needle guard is covering the needle cap (see Figure D) the needle guard has already been activated. Do not use the prefilled syringe.

Get another prefilled syringe that has not been activated and is ready to use (see Figure E).

Figure D shows a needle guard that has already been activated. Do not use a ZARXIO prefilled syringe that has been activated.

Figure D Do Not Use

Figure E shows a needle guard that has not yet been activated. The prefilled syringe is ready for use.

Figure E Ready to Use

Step 9: Choose the injection site:

  • Areas of your body that you may use as injection sites include:

    • the front of your thighs (see Figure F)
    • the lower stomach-area (abdomen), but not the area 2 inches around your navel (belly button) (see Figure F)
    • if a caregiver is giving you the injection
    • upper outer arms (see Figure F and Figure G)
    • upper areas of the buttocks (see Figure G)
  • Choose a different site each time you give yourself an injection.
  • Do not inject into areas where the skin is tender, bruised, red, scaly, or hard. Avoid areas with scars or stretch marks.

Recommended injection sites:

Figure F

Figure G

  1. Step 10. Clean the injection site using a circular motion with the alcohol wipe. Leave it to dry before injecting. Do not touch the cleaned area again before injecting.

Giving your injection

  1. Step 11. Hold the prefilled syringe by the body (the clear plastic needle guard) with the needle pointing up (see Figure H). Holding the syringe with the needle pointing up helps to prevent medicine from leaking out of the needle. Carefully pull the needle cap straight off. Throw away the needle cap.

Figure H Remove needle cap

  1. Step 12. Check the syringe for an air bubble. Gently tap the syringe body with your fingers until the air bubble rises to the top of the syringe (see Figure I). Slowly push the plunger up to push any air out of the syringe and stop when you see a small drop start to appear at the needle tip (see Figure I).

Figure I Check the syringe

  • Your healthcare provider has prescribed either a “full” syringe dose or a “partial” syringe dose of ZARXIO. If you are prescribed a full dose, you will inject all of the medicine from your prefilled syringe. For a full dose, go directly to Step 14.
  • If you are prescribed a partial dose of ZARXIO, start with Step 13.
  • Step 13. Holding the syringe as shown, press slowly on the plunger to push out the excess medicine until the edge of the conical base of the plunger stopper lines up with the syringe marking for your prescribed dose. See Figure J, example for a dose of 0.4 mL. Your dose may be different than the example shown.

Be careful not to touch the needle guard wings before use. The needle guard may be activated too early.

Check again to make sure the correct dose of ZARXIO is in the syringe.

Call your healthcare provider if you have problems measuring or injecting your dose of ZARXIO.

Figure J Partial dose (example for a dose of 0.4 mL)

  1. Step 14. With one hand gently pinch the skin at the injection site. With your other hand insert the needle into your skin at a 45 to 90 degree angle as shown (see Figure K). Push the needle all the way in to make sure that you inject your full dose.

Figure K Insert needle

  1. Step 15. Hold the ZARXIO prefilled syringe as shown (see Figure L). Slowly press down on the plunger as far as it will go so that the plunger head is completely between the needle guard wings.

Figure L Press down on plunger

  1. Step 16. Keep the plunger fully pressed down while you carefully pull the needle straight out from the injection site (see Figure M).

Figure M Pull out needle

  1. Step 17. Slowly release the plunger and allow the needle guard to automatically cover the exposed needle (see Figure N).

Figure N Release plunger

  1. Step 18. There may be a small amount of blood at the injections site. You can press a cotton ball or gauze over the injection site and hold it for 10 seconds. Do not rub the injection site. You may cover the injection site with a small adhesive bandage, if needed.

Disposing of used ZARXIO prefilled syringes

Put your used prefilled syringes in an FDA-cleared sharps disposal container right away after use (see Figure O). Do not throw away (dispose of) ZARXIO prefilled syringes in your household trash.

Figure O Disposing prefilled syringes

If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:

  • made of a heavy-duty plastic,
  • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
  • upright and stable during use,
  • leak-resistant, and
  • properly labeled to warn of hazardous waste inside the container.

When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles, syringes, and prefilled syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal.

Do not reuse the prefilled syringe.

Do not recycle the syringe, or sharps disposal container or throw them into household trash.

Important: Always keep the sharps disposal container out of the reach of children.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Manufactured by:

Sandoz Inc., Princeton, NJ 08540,

US License No. 2003

Revised: 04/2025

Instructions for Use

ZARXIO® (zar-zee-oh)

(filgrastim-sndz)

Injection

Single-Dose Vial

Important Information You Need to Know Before Injecting ZARXIO:

  • Do not inject yourself or someone else until you have been shown how to inject ZARXIO. Your healthcare provider will show you how to prepare and inject ZARXIO properly using the ZARXIO vial and syringe. Talk to your healthcare provider if you have any questions.
  • Do not use the ZARXIO vial if either the seal on the outer pack or the cap of the vial is broken.
  • Keep the ZARXIO vial in the sealed pack until you are ready to use it.
  • Throw away (dispose of) the used ZARXIO vials, syringes, and needles right away after use. Do not re-use ZARXIO vials, syringes, or needles. See “Disposing of used ZARXIO vials, syringes, and needles” at the end of this Instructions for Use.
  • Latex-sensitive individuals: The vial stopper is not made with natural rubber latex.

Storing ZARXIO

  • Store ZARXIO in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Protect ZARXIO from freezing. If frozen, thaw in the refrigerator before use. Throw away (dispose of) if it has been frozen more than 1 time.
  • Store ZARXIO in the original pack to protect it from light.
  • Avoid shaking ZARXIO.
  • Take ZARXIO out of the refrigerator 30 minutes before use and allow it to reach room temperature between 68°F to 77°F (20°C to 25°C) before preparing an injection.
  • If not used right away, ZARXIO may be kept at room temperature for up to 8 days. Throw away (dispose of) any ZARXIO that has been left at room temperature for longer than 8 days.
  • After you inject your dose, throw away (dispose of) any unused ZARXIO left in the vial. Do not save unused ZARXIO in the vial for later use.

Keep ZARXIO and all medicines out of the reach of children.

About the ZARXIO vial:

  • ZARXIO vials come in two strengths. Depending on your prescription, you will receive ZARXIO vials that contain 300 mcg/mL or 480 mcg/1.6 mL of medicine. Your healthcare provider will determine the microgram (mcg) dose in milliliters (mL) that you will need to give based on your body weight.
  • When you receive your ZARXIO vials, always check to see that:

    • the name ZARXIO appears on the pack and vial label.
    • the expiration date on the vial label has not passed. You should not use a vial after the date on the label.
    • the strength of ZARXIO (number of mcg on the pack containing the vial) is the same as what your healthcare provider prescribed.

What you need for your injection:

Included in the pack (see Figure A):

  • A new ZARXIO vial

Figure A

Not included in the pack (see Figure B):

  • New disposable syringe and needle
  • 2 Alcohol wipes
  • Cotton ball or gauze
  • Sharps disposal container
  • Adhesive bandage

Figure B

  • Only use the disposable syringes and needles that your healthcare provider prescribes.
  • Only use the syringes and needles 1 time. Discard (throw away) any used syringes and needles.
  • You should only use a syringe that is marked in tenths of milliliters (mL).
  • Your healthcare provider will show you how to measure the correct dose of ZARXIO. This dose will be measured in milliliters (mL).

See “Disposing of used ZARXIO vials, syringes, and needles” at the end of this Instructions for Use.

Preparing the ZARXIO injection

Step 1. Find a clean, well-lit, flat work surface.

  1. Step 2. Take the ZARXIO vial out of the refrigerator and leave it unopened on your work surface for about 30 minutes so that it reaches room temperature.
  2. Step 3. Wash your hands well with soap and water.
  3. Step 4. Remove the ZARXIO vial from the outer pack.
  4. Step 5. Check the expiration date. Do not use the ZARXIO vial if the expiration date has passed.
  5. Step 6. Inspect the ZARXIO vial. The liquid inside should be clear. The color may be colorless to slightly yellow. Do not use the vial if the liquid contains visible particles, or if the liquid is cloudy or discolored. Return the ZARXIO vial and the package it came into your pharmacy.
  6. Step 7. Do not use a ZARXIO vial if the cap is damaged. Return the vial with damaged cap and the package it came into your pharmacy.
  7. Step 8. Take the cap off the vial. Clean the rubber stopper with one alcohol wipe (see Figure C).

Figure C

  1. Step 9. Check the carton containing the syringe. If the carton has been opened or damaged, do not use that syringe. Dispose of (throw away) that syringe in the sharps disposal container.
  2. Step 10. Hold the syringe by the barrel with the needle cap pointing up (see Figure D). Carefully pull the needle cap straight off and away from your body. Throw away the needle cap into the sharps disposal container.

Figure D

  1. Step 11. Pull back on the plunger and draw air into the syringe that is the same amount (mL) as the dose of ZARXIO that your healthcare provider prescribed.
  2. Step 12. Keep the vial on the flat working surface and insert the needle straight down through the rubber stopper. Do not insert the needle through the rubber stopper more than 1 time.
  3. Step 13. Push the plunger down and inject all the air from the syringe into the vial of ZARXIO (see Figure E).

Figure E

  1. Step 14. Keep the needle in the vial and turn the vial upside down (see Figure F). Make sure that the ZARXIO liquid is covering the tip of the needle.

Figure F

  1. Step 15. Keep the vial upside down and slowly pull back on the plunger to fill the syringe barrel with ZARXIO to the correct marking amount (mL) of medicine that matches the dose your healthcare provider prescribed.
  2. Step 16. Keep the needle in the vial and check for air bubbles in the syringe. If there are air bubbles, gently tap the syringe barrel with your finger until the air bubbles rise to the top (see Figure G). Slowly push the plunger up to push the air bubbles out of the syringe.

Figure G

Step 17. Keep the tip of the needle in the liquid and again pull the plunger back to the number on the syringe barrel that matches your dose. Check again for air bubbles. The air in the syringe will not hurt you, but too large an air bubble can reduce your dose of ZARXIO. If there are still air bubbles, repeat the steps above to remove them.

Step 18. Check again to make sure that you have the correct dose in the syringe. It is important that you use the exact dose prescribed by your healthcare provider. Do not remove the needle from the vial. Lay the vial down on its side with the needle still in the vial.

Step 19: Choose the injection site:

  • Areas of your body that you may use as injection sites include:

    • the front of your thighs (see Figure H)
    • the lower stomach-area (abdomen), but not the area 2 inches around your navel (belly button) (see Figure H)
    • if a caregiver is giving you the injection

      • upper outer arms (see Figure H and Figure I)
      • upper areas of the buttocks (see Figure I)
  • Choose a different site each time you give yourself an injection.
  • Do not inject into areas where the skin is tender, bruised, red, scaly, or hard. Avoid areas with scars or stretch marks.

Figure H

Figure I

  1. Step 20. Clean the injection site using a circular motion with the alcohol wipe. Leave it to dry before injecting. Do not touch the cleaned area again before injecting.

Giving your injection

  1. Step 21. Remove the prepared syringe and needle from the vial.
  2. Step 22. With one hand gently pinch the skin at the injection site. With your other hand insert the needle into your skin at a 45 to 90 degree angle as shown (see Figure J). Push the needle all the way in to make sure that you inject your full dose.

Figure J

  1. Step 23. Hold the syringe as shown (see Figure K). Slowly press down on the plunger as far as it will go.

Figure K

Step 24. Keep the plunger fully pressed down while you carefully pull the needle straight out from the injection site.

Step 25. There may be a small amount of blood at the injection site. You can press a cotton ball or gauze over the injection site and hold it for 10 seconds. Do not rub the injection site. You may cover the injection site with a small adhesive bandage, if needed.

Disposing of used ZARXIO vials, syringes, and needles

Put your used vials, syringes, and needles in an FDA-cleared sharps disposal container right away after use (see Figure L). Do not throw away (dispose of) vials, syringes, and needles in your household trash.

Figure L

If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:

  • made of a heavy-duty plastic,
  • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
  • upright and stable during use,
  • leak-resistant, and
  • properly labeled to warn of hazardous waste inside the container.

When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used syringes and vials. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA’s website at: http://www.fda.gov/safesharpsdisposal .

Do not reuse the vial or syringe.

Do not recycle the vial, syringe, or sharps disposal container or throw them into household trash.

Important: Always keep the sharps disposal container out of the reach of children.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Manufactured by: Sandoz Inc., Princeton, NJ 08540, US License No. 2003

Approved: 08/2024

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 125553 · View the label on DailyMed

Revision date stated in the text: April 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Zarxio

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Leukocyte Growth Factor
Active ingredient Filgrastim
Dosage form Injection, solution
Route Intravenous, Subcutaneous
Marketing status listed in the FDA NDC Directory
Company (applicant) SANDOZ INC
FDA approval BLA 125553Biologics License Application (BLA) Approved March 6, 2015
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
300 mcg/0.5 mL – 0.5 ml in 1 syringe / 1 in 1 blister pack / 1 in 1 carton NDC 61314-318-01
300 mcg/0.5 mL – 0.5 ml in 1 syringe / 5 in 1 blister pack / 2 in 1 carton NDC 61314-318-05
300 mcg/0.5 mL – 0.5 ml in 1 syringe / 1 in 1 blister pack / 1 in 1 carton NDC 61314-318-63
300 mcg/0.5 mL – 0.5 ml in 1 syringe / 5 in 1 blister pack / 2 in 1 carton NDC 61314-318-65
480 mcg/0.8 mL – 0.8 ml in 1 syringe / 1 in 1 blister pack / 1 in 1 carton NDC 61314-326-01
480 mcg/0.8 mL – 0.8 ml in 1 syringe / 5 in 1 blister pack / 2 in 1 carton NDC 61314-326-05
480 mcg/0.8 mL – 0.8 ml in 1 syringe / 1 in 1 blister pack / 1 in 1 carton NDC 61314-326-63
480 mcg/0.8 mL – 0.8 ml in 1 syringe / 5 in 1 blister pack / 2 in 1 carton NDC 61314-326-65

Source: FDA drug labeling via NLM DailyMed, data as of November 20, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.